Showing results (171-180 of 900) with videos related to
Sort By:
Pageof 90
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic LeukemiaNicholas J Short, Elias Jabbour, Trevor Jamison, et al.The American Journal of the Medical Sciences|March 30, 2011
Intra-abdominal splenosis mimicking metastatic cancerNicholas J Short, Teresa G Hayes, Peeyush BhargavaTherapeutic Advances in Hematology|March 28, 2020
Evaluation and management of measurable residual disease in acute lymphoblastic leukemiaIman Abou Dalle, Elias Jabbour, Nicholas J ShortTherapeutic Advances in Hematology|February 9, 2023
Treatment de-escalation in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimensFadi G Haddad, Jacki Sawyers, Nicholas J ShortAmerican Journal of Hematology|October 30, 2021
Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapyKoji Sasaki, Tapan Kadia, Kebede Begna, et al.Current Hematologic Malignancy Reports|June 11, 2011
Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome-positive acute lymphoblastic leukemiaMichael S Mathisen, Susan O'Brien, Deborah Thomas, et al.Blood Cancer Journal|June 10, 2022
Resistance to targeted therapies: delving into FLT3 and IDHSai Prasad Desikan, Naval Daver, Courtney DiNardo, et al.Clinical Lymphoma, Myeloma & Leukemia|September 20, 2023
Early Mortality as a Quality Indicator in Frontline and Salvage Acute Myeloid LeukemiaKoji Sasaki, Farhad Ravandi, Courtney DiNardo, et al.Expert Review of Anticancer Therapy|March 13, 2015
The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemiaDavid S Sanford, Hagop Kantarjian, Susan O'Brien, et al.Advances in Experimental Medicine and Biology|March 22, 2017
Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AMLLucia Masarova, Hagop Kantarjian, Guillermo Garcia-Mannero, et al.Pageof 90